Thomas Gerloff

5.2k total citations · 2 hit papers
31 papers, 4.3k citations indexed

About

Thomas Gerloff is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Thomas Gerloff has authored 31 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pediatrics, Perinatology and Child Health and 10 papers in Pharmacology. Recurrent topics in Thomas Gerloff's work include Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Thomas Gerloff is often cited by papers focused on Drug Transport and Resistance Mechanisms (26 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Thomas Gerloff collaborates with scholars based in Germany, Switzerland and United States. Thomas Gerloff's co-authors include Ivar Roots, Ingolf Cascorbi, Andreas Johne, Sven Hoffmeyer, Ulrich Brinkmann, Oliver von Richter, Oliver Burk, Michel Eichelbaum, J. Brockmöller and Bruno Stieger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Thomas Gerloff

30 papers receiving 4.2k citations

Hit Papers

Functional polymorphisms of the human multidrug-resistanc... 1998 2026 2007 2016 2000 1998 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
    2000 2.0k citations Andreas Johne, Ingolf Cascorbi et al. profile →
  2. The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver
    1998 769 citations Thomas Gerloff, Bruno Stieger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Gerloff Germany 23 3.2k 1.8k 1.0k 1.0k 712 31 4.3k
Kazuto Yasuda United States 30 2.7k 0.8× 1.4k 0.7× 528 0.5× 2.6k 2.5× 1.0k 1.4× 59 5.4k
Oliver von Richter Germany 25 2.9k 0.9× 1.8k 1.0× 448 0.4× 1.5k 1.4× 973 1.4× 66 4.6k
Andreas Johne Germany 23 2.4k 0.8× 1.5k 0.8× 442 0.4× 1.1k 1.1× 706 1.0× 85 4.2k
Yunhai Cui Germany 22 3.5k 1.1× 1.9k 1.0× 733 0.7× 807 0.8× 887 1.2× 32 4.3k
Kousei Ito Japan 30 2.2k 0.7× 1.1k 0.6× 693 0.7× 785 0.8× 818 1.1× 119 3.5k
Inka Leier Germany 26 4.0k 1.3× 2.1k 1.1× 990 1.0× 592 0.6× 1.4k 1.9× 35 5.2k
Mahfoud Assem United States 22 1.4k 0.4× 722 0.4× 389 0.4× 1.5k 1.5× 851 1.2× 33 3.2k
Frederick J. Suchy United States 48 3.4k 1.1× 1.3k 0.7× 3.6k 3.5× 531 0.5× 1.4k 2.0× 148 7.1k
Maciej J. Zamek‐Gliszczynski United States 33 2.0k 0.6× 1.1k 0.6× 243 0.2× 945 0.9× 670 0.9× 62 2.9k
P. L. M. Jansen Netherlands 34 1.7k 0.5× 1.2k 0.6× 898 0.9× 467 0.5× 1.0k 1.5× 79 3.8k

Countries citing papers authored by Thomas Gerloff

Since Specialization
Citations

This map shows the geographic impact of Thomas Gerloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gerloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gerloff more than expected).

Fields of papers citing papers by Thomas Gerloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gerloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gerloff. The network helps show where Thomas Gerloff may publish in the future.

Co-authorship network of co-authors of Thomas Gerloff

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gerloff. A scholar is included among the top collaborators of Thomas Gerloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gerloff. Thomas Gerloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roots, Ivar, Julia Kirchheiner, Dieter Schwarz, et al.. (2007). Genotype and Phenotype Relationship in Drug Metabolism. PubMed. 81–100. 4 indexed citations
2.
Fiedler, Thomas, Carsten Büning, Enno Gentz, et al.. (2007). Possible role of MDR1 two-locus genotypes for young-age onset ulcerative colitis but not Crohn’s disease. European Journal of Clinical Pharmacology. 63(10). 917–925. 30 indexed citations
3.
Gerloff, Thomas, Jessica Mwinyi, Andreas Johne, et al.. (2006). Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin’s cholesterol lowering capabilities and basal sterol serum levels. Naunyn-Schmiedeberg s Archives of Pharmacology. 373(1). 45–50. 22 indexed citations
4.
Roots, Ivar, et al.. (2006). In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms. Pharmacogenetics and Genomics. 16(12). 855–861. 38 indexed citations
5.
6.
Johne, Andreas, Thomas Gerloff, & Ingrid Mai. (2005). Arzneimitteluntersuchungen beim Menschen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 48(4). 397–400. 1 indexed citations
7.
Roots, Ivar, Thomas Gerloff, Christian Meisel, et al.. (2004). Pharmacogenetics‐Based New Therapeutic Concepts. Drug Metabolism Reviews. 36(3-4). 617–638. 23 indexed citations
8.
Gerloff, Thomas. (2004). Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(1). 69–77. 43 indexed citations
9.
Meisel, Christian, Thomas Gerloff, Julia Kirchheiner, et al.. (2003). Implications of pharmacogenetics for individualizing drug treatment and for study design. Journal of Molecular Medicine. 81(3). 154–167. 41 indexed citations
10.
Geier, Andreas, Christoph G. Dietrich, Sebastian Voigt, et al.. (2003). Effects of Proinflammatory Cytokines on Rat Organic Anion Transporters During Toxic Liver Injury and Cholestasis. Hepatology. 38(2). 345–354. 177 indexed citations
11.
Cascorbi, Ingolf, et al.. (2003). Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. European Journal of Clinical Pharmacology. 59(4). 303–312. 197 indexed citations
12.
Gerloff, Thomas, Andreas Geier, Ivar Roots, Peter J. Meier, & Carsten Gartung. (2002). Functional analysis of the rat bile salt export pump gene promoter. European Journal of Biochemistry. 269(14). 3495–3503. 37 indexed citations
13.
Geier, Andreas, Christoph G. Dietrich, Thomas Gerloff, et al.. (2002). Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1609(1). 87–94. 72 indexed citations
14.
Gerloff, Thomas, Andreas Johne, Kersti Oselin, et al.. (2002). MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. British Journal of Clinical Pharmacology. 54(6). 610–616. 124 indexed citations
15.
Geier, Andreas, Thomas Gerloff, Christoph G. Dietrich, et al.. (2002). Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. Journal of Hepatology. 37(2). 198–205. 81 indexed citations
16.
17.
Gerloff, Thomas, Andreas Geier, Bruno Stieger, et al.. (1999). Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology. 117(6). 1408–1415. 74 indexed citations
18.
Gerloff, Thomas, P.J. Meier, & Bruno Stieger. (1998). Taurocholate induces preferential release of phosphatidylcholine from rat liver canalicular vesicles. Liver International. 18(5). 306–312. 16 indexed citations
19.
Madon, Jerzy, Uta Eckhardt, Thomas Gerloff, Bruno Stieger, & Peter J. Meier. (1997). Functional expression of the rat liver canalicular isoform of the multidrug resistance‐associated protein. FEBS Letters. 406(1-2). 75–78. 90 indexed citations
20.
Kullak‐Ublick, Gerd A., Thomas Gerloff, Bruno Hagenbuch, et al.. (1996). Expression of a rat liver phosphatidylcholine translocator in Xenopus laevis oocytes. Hepatology. 23(5). 1254–1259. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuto Yasuda Breakdown of academic impact, for papers by Oliver von Richter Breakdown of academic impact, for papers by Andreas Johne Breakdown of academic impact, for papers by Yunhai Cui Breakdown of academic impact, for papers by Kousei Ito Breakdown of academic impact, for papers by Inka Leier Breakdown of academic impact, for papers by Mahfoud Assem Breakdown of academic impact, for papers by Frederick J. Suchy Breakdown of academic impact, for papers by Maciej J. Zamek‐Gliszczynski Breakdown of academic impact, for papers by P. L. M. Jansen
Rankless by CCL
2026